Elitecon appoints Vipin Sharma and Pradeep Kumar as Executive Directors
Elitecon International Limited has appointed Vipin Sharma and Pradeep Kumar as Executive Additional Directors effective July 22, 2026. The move restores Board quorum and places experienced leadership at the helm to drive operational revival amidst resumed banking operations. Shareholder approval is pending.

*this image is generated using AI for illustrative purposes only.
elitecon international appointed Vipin Sharma and Pradeep Kumar as Executive Additional Directors on July 22, 2026, marking a strategic shift in its leadership structure to drive operational revival. The appointments were approved by Kumar Anubhav Upadhyay, the sole continuing Director, during a Board meeting convened under Section 174(2) of the Companies Act, 2013, to restore requisite quorum following the cessation of Independent Directors. This leadership renewal coincides with the resumption of banking operations, positioning the company to advance its recovery agenda in the second half of the financial year.
The Board designated both appointees as Executive Directors, signaling their active role in management rather than a non-executive capacity. Vipin Sharma (DIN: 01739519) and Pradeep Kumar (DIN: 00209355) will hold office until the next Annual General Meeting or the last date it should have been held, whichever is earlier. The company is required to seek shareholder approval for these appointments at the next general meeting or within three months from the date of appointment, in accordance with Regulation 17(1C) of the SEBI LODR Regulations.
Leadership Return and Operational Focus
Vipin Sharma’s return represents a significant development for the company’s turnaround efforts. A promoter and second-generation entrepreneur with over three decades of experience across pharmaceuticals, perfumery, FMCG, and tobacco, Sharma previously served as Managing Director until April 2026. He had stepped back from executive office with the intention of retiring from active corporate life but returned to lead the operational revival. Sharma holds 16,00,00,000 equity shares, representing approximately 10.01% of the paid-up equity share capital. Notably, he is a noticee under a SEBI Ex-Parte Interim Order dated March 30, 2026, though the order does not expressly restrain him from holding office as a director.
Pradeep Kumar joins the Board from within the company’s group, serving as a Director of Golden Cryo Private Limited, a subsidiary. He brings over 28 years of professional experience, including 23 years in construction and infrastructure and five years in tobacco industry operations. Kumar holds a B. Tech in Production Engineering from Marathwada University and does not hold any equity shares in Elitecon International Limited.
Director Details
| Particulars | Vipin Sharma | Pradeep Kumar |
|---|---|---|
| DIN | 01739519 | 00209355 |
| Date of Appointment | July 22, 2026 | July 22, 2026 |
| Role | Executive Additional Director | Executive Additional Director |
| Shares Held | 16,00,00,000 | Nil |
| Shareholding Percentage | ~10.01% | Nil |
| SEBI Status | Noticee under Interim Order dated March 30, 2026 | Not debarred |
Strategic Outlook
The Board intends to further strengthen the company’s leadership by inducting experienced key managerial personnel and independent directors in the coming period. Vipin Sharma stated that his primary purpose for returning is to lead the revival with "vigour, purpose and discipline," assuring stakeholders that the company will repay their confidence through work. The meeting, which commenced at 5:45 P.M. and concluded at 6:15 P.M., transacted no other business beyond these critical appointments.
Historical Stock Returns for Elitecon International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.78% | -9.32% | -14.26% | -62.43% | -62.43% | -62.43% |
How might Vipin Sharma's status as a noticee under a SEBI Ex-Parte Interim Order impact investor confidence and the company's ability to secure new financing during its operational revival?
What specific operational milestones or financial targets has the new leadership set for the second half of the fiscal year to demonstrate progress in the recovery agenda?
Given the cessation of Independent Directors, what is the timeline and criteria for appointing new independent directors to ensure regulatory compliance and corporate governance standards?


































